Mark E. Smolkin
- Immunology top 2%
- Immunotherapy and Immune Responses 30
- T-cell and B-cell Immunology 14
- Immune Cell Function and Interaction 5
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 7
- Cancer Research top 10%
- Molecular Biology top 10%
- vaccines and immunoinformatics approaches 17
-
- Bladder and Urothelial Cancer Treatments 6
-
- Cardiac, Anesthesia and Surgical Outcomes 5
- Co-authors
- Craig L. SlingluffGina R. PetroniJames W. PattersonKimberly A. Chianese‐BullockDonna H. DeaconLynn T. DengelGulsun ErdagWilliam W. Grosh
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Cancer Immunology Immunotherapy (9 papers)Journal for ImmunoTherapy of Cancer (8 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesQatarNetherlands
In The Last Decade
Mark E. Smolkin
83 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 133
- Immunology 1.5k
- Oncology 1.5k
- Cancer Research 222
- Pulmonary and Respiratory Medicine 461
- Molecular Biology 939
Countries citing papers authored by Mark E. Smolkin
This map shows the geographic impact of Mark E. Smolkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Smolkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Smolkin more than expected).
Fields of papers citing papers by Mark E. Smolkin
This network shows the impact of papers produced by Mark E. Smolkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Smolkin. The network helps show where Mark E. Smolkin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Smolkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 14 | |
| 4 | 2020 | 12 | |
| 5 | 2020 | 19 | |
| 6 | 2017 | 50 | |
| 7 | 2016 | 25 | |
| 8 | 2015 | 10 | |
| 9 | 2015 | 9 | |
| 10 | 2014 | 23 | |
| 11 | 2013 | 28 | |
| 12 | 2012 | 439 | |
| 13 | 2012 | 52 | |
| 14 | 2010 | 24 | |
| 15 | 2009 | 129 | |
| 16 | 2009 | 29 | |
| 17 | 2008 | 21 | |
| 18 | 2007 | 6 | |
| 19 | 2006 | 40 | |
| 20 | 2004 | 12 |
About Mark E. Smolkin
Mark E. Smolkin is a scholar working on Immunology, Oncology, Internal Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 86 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (30 papers), vaccines and immunoinformatics approaches (17 papers), T-cell and B-cell Immunology (14 papers), Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers), Immune Cell Function and Interaction (5 papers) and Cardiac, Anesthesia and Surgical Outcomes (5 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.5k citations), Cancer Research (222 citations), Pulmonary and Respiratory Medicine (461 citations) and Molecular Biology (939 citations). Mark E. Smolkin has collaborated with scholars based in United States, Qatar and Netherlands. Frequent co-authors include Craig L. Slingluff, Gina R. Petroni, James W. Patterson, Kimberly A. Chianese‐Bullock, Donna H. Deacon, Lynn T. Dengel, Gulsun Erdag, William W. Grosh, Walter C. Olson and Sofia M. Shea. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, Journal of Immunotherapy and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.